The findings, led by researchers at Copenhagen University Hospital, contribute to a growing body of research suggesting that #GLP1 receptor agonists such as semaglutide may have applications beyond obesity and type 2 #diabetes treatment, including potential use in substance use disorders
As with any medication, there may be potential side effects and interactions with other drugs, so regular follow-up with a healthcare provider is essential
When the medication becomes less potent, it may deliver a lower dose than intended, making treatment less effective
By understanding the science behind semaglutide and its interaction with hormones, women can feel more confident about their health and treatment choices
Clinical trials show higher average weight loss with tirzepatidearound 22.5% versus 14.9% for semaglutide at maximum doses
JAMA, 323 (9), 854862